• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PGC-1α 可保护神经元并改变肌萎缩侧索硬化症小鼠模型中的疾病进展。

PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model.

机构信息

Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

出版信息

Muscle Nerve. 2011 Dec;44(6):947-56. doi: 10.1002/mus.22217.

DOI:10.1002/mus.22217
PMID:22102466
Abstract

INTRODUCTION

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. We sought to determine whether peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) would have a beneficial effect on this disease.

METHODS

PGC-1α transgenic mice were crossed with SOD1 mutant G93A DL mice.

RESULTS

We observed a moderate but non-significant increase in average lifespan in PGC-1α/G93A DL mice, as compared with G93A DL mice (292 ± 3 days vs. 274 ± 7 days). Although the onset of ALS was not altered, progression of the disease was significantly slower (≈34% increase in duration) in the PGC-1α/G93A DL mice. These mice also exhibited markedly improved performance on the rotarod test, and the improved motor activity was associated with a decreased loss of motor neurons and less degeneration of neuromuscular junctions.

CONCLUSION

A sustained level of excitatory amino acid transporter protein 2 (EAAT2) in astrocytes of the PGC-1α/G93A DL mice may contribute to neuronal protection.

摘要

简介

肌萎缩侧索硬化症(ALS)是一种毁灭性的神经退行性疾病。我们试图确定过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC-1α)是否对这种疾病有有益的影响。

方法

将 PGC-1α 转基因小鼠与 SOD1 突变 G93A DL 小鼠杂交。

结果

与 G93A DL 小鼠相比,我们观察到 PGC-1α/G93A DL 小鼠的平均寿命有适度但无统计学意义的延长(292±3 天 vs. 274±7 天)。虽然 ALS 的发病没有改变,但 PGC-1α/G93A DL 小鼠的疾病进展明显较慢(持续时间延长约 34%)。这些小鼠在旋转棒试验中的表现也明显改善,运动活动的改善与运动神经元的减少和运动神经元减少相关神经肌肉接头的退化。

结论

PGC-1α/G93A DL 小鼠星形胶质细胞中兴奋性氨基酸转运蛋白 2(EAAT2)的持续水平可能有助于神经元保护。

相似文献

1
PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model.PGC-1α 可保护神经元并改变肌萎缩侧索硬化症小鼠模型中的疾病进展。
Muscle Nerve. 2011 Dec;44(6):947-56. doi: 10.1002/mus.22217.
2
Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.过氧化物酶体增殖物激活受体γ共激活因子-1α在肌萎缩侧索硬化症中的过表达:两种转基因动物的故事。
Biomolecules. 2020 May 13;10(5):760. doi: 10.3390/biom10050760.
3
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.导致肌萎缩侧索硬化症的突变对大脑与外周组织中PGC-1α表达和功能的影响存在差异。
Neurobiol Dis. 2017 Jan;97(Pt A):36-45. doi: 10.1016/j.nbd.2016.11.001. Epub 2016 Nov 3.
4
Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.突变型 SOD1G93A 触发脊髓运动神经元中线粒体片段化:SIRT3 和 PGC-1α 的神经保护作用。
Neurobiol Dis. 2013 Mar;51:72-81. doi: 10.1016/j.nbd.2012.07.004. Epub 2012 Jul 20.
5
Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis.过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)可改善肌萎缩侧索硬化症小鼠模型的运动性能和存活率。
Mol Neurodegener. 2011 Jul 19;6(1):51. doi: 10.1186/1750-1326-6-51.
6
Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.PGC-1α 活性升高可维持线粒体生物发生和肌肉功能,但不能延长遗传性 ALS 小鼠模型的生存期。
Cell Metab. 2012 May 2;15(5):778-86. doi: 10.1016/j.cmet.2012.03.019.
7
Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.PGC-1α 和 PGC-1α 调节因子在 SOD1G93A ALS 小鼠模型和散发性 ALS 患者中的 mRNA 表达降低。
J Neuropathol Exp Neurol. 2012 Dec;71(12):1064-74. doi: 10.1097/NEN.0b013e318275df4b.
8
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.敲除代谢型谷氨酸受体 1 可改善肌萎缩侧索硬化症 SOD1(G93A)小鼠模型的生存和疾病进展。
Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19.
9
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中线粒体网络基因和 miRNA 的破坏。
Neurobiol Dis. 2013 Jan;49:107-17. doi: 10.1016/j.nbd.2012.08.015. Epub 2012 Sep 4.
10
Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.多功能铁螯合剂M30与强化饮食对肌萎缩侧索硬化小鼠模型的叠加神经保护作用
Neurotox Res. 2016 Feb;29(2):208-17. doi: 10.1007/s12640-015-9574-4. Epub 2015 Nov 18.

引用本文的文献

1
Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential.PGC-1α在神经系统疾病中的作用研究见解:机制与治疗潜力
Front Aging Neurosci. 2025 Feb 12;16:1454735. doi: 10.3389/fnagi.2024.1454735. eCollection 2024.
2
Neuronal Activity-Dependent Gene Dysregulation in iNeuronal Models of ALS/FTD Pathogenesis.肌萎缩侧索硬化症/额颞叶痴呆发病机制的诱导神经元模型中神经元活动依赖性基因失调
bioRxiv. 2025 Jan 27:2025.01.27.632228. doi: 10.1101/2025.01.27.632228.
3
A 6-Minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models.
用于实验性外周动脉疾病模型治疗测试的6分钟肢体功能评估
JACC Basic Transl Sci. 2024 Oct 23;10(1):88-103. doi: 10.1016/j.jacbts.2024.08.011. eCollection 2025 Jan.
4
A 6-minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models.用于实验性外周动脉疾病模型治疗测试的6分钟肢体功能评估。
bioRxiv. 2024 Mar 27:2024.03.21.586197. doi: 10.1101/2024.03.21.586197.
5
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases.过氧化物酶体增殖物激活受体γ共激活因子-1(PGC-1)家族在生理和病理生理过程及疾病中的作用。
Signal Transduct Target Ther. 2024 Mar 1;9(1):50. doi: 10.1038/s41392-024-01756-w.
6
Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis.线粒体稳态失衡作为肌萎缩侧索硬化症的早期特征和治疗靶点。
Int J Mol Sci. 2023 Nov 27;24(23):16833. doi: 10.3390/ijms242316833.
7
Mitochondrial regulation of local supply of energy in neurons.线粒体对神经元局部能量供应的调节。
Curr Opin Neurobiol. 2023 Aug;81:102747. doi: 10.1016/j.conb.2023.102747. Epub 2023 Jun 29.
8
Antioxidant-based neuroprotective effect of dimethylsulfoxide against induced traumatic brain injury in a rats model.二甲基亚砜对大鼠模型中诱导性创伤性脑损伤的基于抗氧化剂的神经保护作用。
Front Pharmacol. 2022 Oct 6;13:998179. doi: 10.3389/fphar.2022.998179. eCollection 2022.
9
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的生物能量改变和代谢稳态失衡。
Neurotherapeutics. 2022 Jul;19(4):1102-1118. doi: 10.1007/s13311-022-01262-3. Epub 2022 Jun 30.
10
Covering the Role of PGC-1α in the Nervous System.探讨过质体生糖基因激活蛋白-1α(PGC-1α)在神经系统中的作用。
Cells. 2021 Dec 30;11(1):111. doi: 10.3390/cells11010111.